Literature DB >> 21052966

The hematopoietic growth factors in the myelodysplastic syndromes.

Jose Ortega1, Rami Komrokji, Alan F List.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21052966     DOI： 10.1007/978-1-4419-7073-2_20

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  1 in total

1.  GPX3 methylation is associated with hematologic improvement in low-risk myelodysplastic syndrome patients treated with Pai-Neng-Da.

Authors:  Shujun Yang; Tong Gao; Zhonghua Zheng; Binbin Lai; Lixia Sheng; Zhijuan Xu; Xiao Yan; Jiaping Wang; Shiwei Duan; Guifang Ouyang
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.